We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Rambus
RMBS
$10.6B
| $2.43M | 0.01% |
316,804
+54,275
| +21% | +$472K |
|
1527
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $2.43M | 0.01% |
8,020
+4,470
| +126% | +$1.49M |
|
1528
National Bank Holdings
NBHC
$1.93B
| $2.42M | 0.01% |
78,464
+15,138
| +24% | +$524K |
|
|
FOLD
1529
DELISTED
Amicus Therapeutics
FOLD
| $2.42M | 0.01% |
252,354
+81,792
| +48% | +$899K |
|
1530
Penske Automotive Group
PAG
$14.2B
| $2.4M | 0.01% |
59,532
+780
| +1% | +$33.7K |
|
1531
Helix Energy Solutions
HLX
$1.37B
| $2.4M | 0.01% |
442,665
+102,886
| +30% | +$838K |
|
|
BDN
1532
Brandywine Realty Trust
BDN
$551M
| $2.37M | 0.01% |
184,142
+3,630
| +2% | +$51.3K |
|
|
AMWD
1533
DELISTED
American Woodmark
AMWD
| $2.37M | 0.01% |
42,515
+7,009
| +20% | +$447K |
|
|
GCP
1534
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.37M | 0.01% |
96,433
+30,466
| +46% | +$783K |
|
1535
Liberty Latin America Class C
LILAK
$1.66B
| $2.35M | 0.01% |
188,821
+57,228
| +43% | +$883K |
|
1536
iRhythm Holdings
IRTC
$4.09B
| $2.35M | 0.01% |
33,834
+12,128
| +56% | +$919K |
|
1537
Marcus Corp
MCS
$949M
| $2.35M | 0.01% |
59,514
+10,767
| +22% | +$445K |
|
1538
Pacira BioSciences
PCRX
$979M
| $2.35M | 0.01% |
54,649
+17,258
| +46% | +$806K |
|
|
EGOV
1539
DELISTED
NIC Inc
EGOV
| $2.35M | 0.01% |
188,330
+31,933
| +20% | +$426K |
|
1540
Paylocity
PCTY
$7.91B
| $2.35M | 0.01% |
38,992
+13,153
| +51% | +$843K |
|
1541
Towne Bank
TOWN
$3.5B
| $2.35M | 0.01% |
97,939
+26,709
| +37% | +$733K |
|
1542
LGI Homes
LGIH
$1.43B
| $2.35M | 0.01% |
51,866
+9,551
| +23% | +$403K |
|
1543
McGrath RentCorp
MGRC
$2.96B
| $2.34M | 0.01% |
45,536
+10,161
| +29% | +$523K |
|
1544
Agios Pharmaceuticals
AGIO
$1.89B
| $2.34M | 0.01% |
50,808
-1,808
| -3% | -$112K |
|
1545
National Vision
EYE
$1.85B
| $2.33M | 0.01% |
82,872
+39,942
| +93% | +$1.52M |
|
|
BPYU
1546
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $2.33M | 0.01% |
144,948
-12,071
| -8% | -$220K |
|
|
ADSW
1547
DELISTED
Advanced Disposal Services Inc
ADSW
| $2.33M | 0.01% |
97,329
+32,707
| +51% | +$845K |
|
1548
Heron Therapeutics
HRTX
$95.5M
| $2.32M | 0.01% |
89,541
+30,712
| +52% | +$844K |
|
|
XLRN
1549
DELISTED
Acceleron Pharma
XLRN
| $2.32M | 0.01% |
53,334
+16,757
| +46% | +$837K |
|
1550
Ingersoll Rand
IR
$34.9B
| $2.32M | 0.01% |
113,543
+10,016
| +10% | +$246K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.